NPI: 1255645644 · MT PLEASANT, SC 29466 · General Acute Care Hospital · NPI assigned 07/28/2010
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (VP REIMBURSEMENT) |
| NPI Enumeration Date | 07/28/2010 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,658 | $217K |
| 2019 | 8,813 | $200K |
| 2020 | 6,412 | $176K |
| 2021 | 7,758 | $249K |
| 2022 | 9,735 | $583K |
| 2023 | 12,137 | $610K |
| 2024 | 11,284 | $431K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,064 | 6,553 | $469K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,760 | 3,273 | $250K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,180 | 1,075 | $195K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,724 | 2,463 | $193K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,371 | 1,313 | $180K |
| 81025 | 2,715 | 2,527 | $179K | |
| 80053 | Comprehensive metabolic panel | 2,823 | 2,508 | $160K |
| 81003 | 2,853 | 2,679 | $143K | |
| 36415 | Collection of venous blood by venipuncture | 952 | 853 | $83K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,508 | 1,260 | $82K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 907 | 854 | $80K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,695 | 4,289 | $73K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 554 | 508 | $39K |
| 81001 | 1,398 | 1,270 | $33K | |
| 70450 | Computed tomography, head or brain; without contrast material | 521 | 485 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 333 | 318 | $25K |
| 71046 | Radiologic examination, chest; 2 views | 674 | 629 | $24K |
| J7050 | Infusion, normal saline solution, 250 cc | 68 | 54 | $23K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,144 | 1,005 | $23K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,325 | 2,103 | $20K |
| 71045 | Radiologic examination, chest; single view | 1,550 | 1,403 | $20K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 65 | 62 | $19K |
| J3490 | Unclassified drugs | 137 | 105 | $16K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 163 | 156 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 735 | 353 | $15K |
| 84484 | 1,650 | 1,300 | $11K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 44 | 40 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 90 | 83 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 45 | 45 | $7K |
| 85027 | 1,710 | 1,485 | $6K | |
| 87430 | 42 | 36 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 193 | 186 | $5K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 75 | 75 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 14 | 14 | $4K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 58 | 58 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 882 | 773 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,578 | 1,380 | $3K |
| 87428 | 14 | 14 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4,547 | 3,920 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,765 | 2,433 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 47 | 40 | $1K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 31 | 13 | $926.75 |
| A9270 | Non-covered item or service | 914 | 688 | $706.93 |
| 76642 | 18 | 14 | $608.81 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 14 | 14 | $515.18 |
| 59025 | Fetal non-stress test | 12 | 12 | $458.97 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 34 | 30 | $428.39 |
| 80076 | 583 | 549 | $158.89 | |
| 80061 | Lipid panel | 57 | 54 | $58.63 |
| 84443 | Thyroid stimulating hormone (TSH) | 221 | 202 | $49.04 |
| 83605 | 395 | 337 | $20.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 899 | 731 | $9.96 |
| 87040 | 30 | 26 | $9.10 | |
| 83690 | 1,505 | 1,375 | $5.75 | |
| 85610 | 48 | 38 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 104 | 85 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 556 | 307 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 154 | 146 | $0.00 |
| 83880 | 75 | 69 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 430 | 373 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 16 | 12 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 229 | 216 | $0.00 |
| 83735 | 572 | 474 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 743 | 643 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 16 | 16 | $0.00 |
| 85379 | 52 | 43 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 16 | 13 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 45 | 40 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 55 | 51 | $0.00 |